TA
GSK icon

Tiedemann Advisors’s GSK GSK Stock Holding History

Tiedemann Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-34,109
Closed -$1.83M – 272
2017
Q3 		$1.83M Buy
+34,109
New +$1.73M 0.16% 106
2017
Q1 		– Sell
-30,361
Closed -$1.46M – 404
2016
Q4 		$1.46M Buy
+30,361
New +$1.5M 0.15% 114

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Tiedemann Advisors's GSK Position: Q4 2017 in Review

Tiedemann Advisors sold out of GSK (GSK) in Q4 2017, closing a stake of 34,109 shares — an estimated $1.83M sold.

Tiedemann Advisors first reported a position in GSK in Q4 2016 and held it in 2 quarters. The position peaked at $1.83M in Q3 2017. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2017.

  • Tiedemann Advisors reported no remaining GSK position as of Q4 2017 after selling out during the quarter.
  • Tiedemann Advisors sold 34,109 GSK shares in Q4 2017, an estimated $1.83M.
  • Tiedemann Advisors first reported a position in GSK in Q4 2016 and held it in 2 quarters.
  • Tiedemann Advisors's GSK position peaked at $1.83M in Q3 2017.
  • 763 funds tracked by Wall St. Rank held GSK as of Q4 2017.

Based on Tiedemann Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.